Month: June 2020

SAN CARLOS, Calif., June 09, 2020 (GLOBE NEWSWIRE) — Check Point® Software Technologies Ltd. (NASDAQ: CHKP), a leading provider of cybersecurity solutions globally, has today released the findings of a new survey showing how organizations managed their cyber-security during the lockdowns forced by the Covid-19 pandemic, and also listing their security priorities and concerns over the coming months as they move to the ‘new normal.’Over 86% of respondents said their biggest IT challenge during the pandemic was moving to mass remote working, and their biggest security concern was maintaining VPN capacity for staff.  Key findings from the survey of over 270 IT and security professionals globally are:Top security concerns at the start of Covid-19 lockdowns:  62% of respondents said their main concern during initial lockdowns was maintaining...

RANCHO CUCAMONGA, Calif., June 09, 2020 (GLOBE NEWSWIRE) — Amphastar® Pharmaceuticals, Inc., (NASDAQ: AMPH) (“Amphastar”), today announces that the U.S. Food and Drug Administration (“FDA”) has approved its Abbreviated New Drug Application (“ANDA”) for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial. Amphastar’s newly approved drug product was determined by the FDA to be therapeutically equivalent to Quelicin™ (Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial) distributed in the United States by Pfizer, Inc. Succinylcholine Chloride Injection is for intramuscular and intravenous use. It is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.Amphastar’s...

THE WOODLANDS, Texas, June 09, 2020 (GLOBE NEWSWIRE) — Conn’s, Inc. (NASDAQ: CONN) (“Conn’s” or the “Company”), a specialty retailer of furniture and mattresses, home appliances, consumer electronics and home office products, and provider of consumer credit, today announced its financial results for the quarter ended April 30, 2020.“Our response to the COVID-19 pandemic is focused on protecting the health and safety of our employees and customers, while providing essential home goods and financial products to our communities. As an essential business, we have maintained store operations throughout the COVID-19 pandemic through a mix of modified operating hours and enhanced employee programs, including temporarily increasing hourly wages by $2 per hour to support our front-line employees and implementing a work from home program...

Developed a high performance COVID-19 Antibody TestSeveral customer contracts signed for MosaiQ system and COVID-19 Antibody TestTransfusion Dx Expanded Immunohematology (IH) Field Trials have restarted following COVID related delaysInitial Serological Disease Screening (SDS) CE Mark obtainedContinued Strong Top Line Growth in Fourth Quarter and Full Year JERSEY, Channel Islands, June 09, 2020 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today summarized recent key achievements. These included Quotient’s rapid development of a high performance COVID-19 antibody test based on its innovative MosaiQ™ platform and several commercial MosaiQ contracts. Quotient’s European Field Trials in transfusion diagnostics recently...

Key PointsNMRC requests Pre-IND meeting with FDA on the development of a new oral therapeutic targeting Campylobacter and ETECTwo human phase II clinical trials to be conducted in 2021One trial will focus on the ability of the hyperimmune product to protect volunteers against moderate to severe campylobacteriosisThe second trial will focus on ETEC infectionsMELBOURNE, Australia, June 09, 2020 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on developing and commercializing oral immunotherapeutics for the prevention and treatment of gut mediated pathogens, today is pleased to provide shareholders with an update on the company’s research collaboration with the Naval Medical Research Center (NMRC) to develop and clinically evaluate a new therapeutic against campylobacter...

                       Company’s advanced Sensors, RF & HPA and Power Management platforms provide comprehensive automotive technology solutions    MIGDAL HAEMEK, Israel, June 9, 2020 –Tower Semiconductor (NASDAQ/TASE: TSEM), the leader in high-value analog semiconductor foundry solutions, today announced its participation at AutoSensONLINE 2020 and its online presentation, “Automotive Radar: Technologies and Tradeoffs” presented by Amol Kalburge, Sr. Director of Analog IC Marketing and Head of Tower Semiconductor’s Automotive Program, on June 11, 2020 at 16:30 BST.The presentation will address the important role Radars are playing in today’s automotive market (as part of vehicle’s ADAS sensors suite) with increasing levels of autonomy, providing an overview of  Radar technologies available today and their various trade-offs. With...

Company Prepares for App Approval, Release and Launch EventsCAMPBELL, CA, June 09, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Friendable, Inc. (OTC: FDBL) announced today, that it has entered into an agreement with Eclectic Artists, LLC., an entertainment company with divisions focusing on concerts and artist representations, to secure artists for a Fan Pass launch event, to be announced in the coming weeks.“Eclectic Artists is excited to have partnered with Fan Pass. This is an artist platform that is like no other we have seen, allowing a custom tailored and exclusive opportunity for both our artists, as well as their fans. Eclectic Artists focuses on concerts and artist representation and has also established itself as a leader in the college concert market; we take pride in our professional and top-quality services. Our...

ATLANTA, June 09, 2020 (GLOBE NEWSWIRE) — HD Supply Holdings, Inc. (NASDAQ: HDS), one of the largest industrial distributors in North America, today reported Net sales of $1.4 billion for the first quarter of fiscal 2020 ended May 3, 2020, a decrease of $98 million, or 6.6 percent, as compared to the first quarter of fiscal 2019.“The COVID-19 pandemic has created extraordinary challenges, but our focus has remained clear. We have prioritized the health and well-being of our associates and their families while continuing to serve our customers and our communities.  Our associates have worked tirelessly to fulfill our responsibilities and I am proud of each and every one of them,” stated Joe DeAngelo, Chairman and CEO of HD Supply. “We are encouraged by improving results in May, and we will continue to support our...

VANCOUVER, Washington, June 09, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, and Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development, will host an investment community conference call on Thursday, June 11, 2020, to provide a comprehensive update on several recent clinical and regulatory developments, potential uplisting and its timing, potential licensing and/or distribution agreements.Management will dedicate approximately 30-40 minutes to address questions from analysts and investors.Date:  Thursday, June 11, 2020Time:  1:00 p.m. PT...

Aspocomp Group Plc, Company Announcement, June 9, 2020 at 12:35 noon